Assessment of Human Cytomegalovirus Viral Load in Kidney Transplant Recipients in Tehran, Iran

Document Type : Original Research

Authors
1 Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
2 Labbafinezhad hospital, Shahid Beheshti University of Medical Sciences
Abstract
Aims: The purpose of this study is to evaluate the viral load of active human cytomegalovirus (HCMV) infection in the plasma samples of people suspected of kidney transplant rejection and to investigate the host and risk factors related to the activation of HCMV in these patients.

Materials & Methods: This cross-sectional study was conducted between December 2022 and June 2023. In this study, 98 blood samples related to patients suspected of kidney transplant rejection referring to Labbafinezhad hospital in Tehran were collected. The samples were tested by the GeneProof Cytomegalovirus (CMV) PCR Kit to determine HCMV viral load. ROC curve analysis was used to determine the viral load cutoff point.

Findings: HCMV viremia was detected in 18 (18.36%) of 98 transplant recipients. The median viral load in the HCMV viremia group was 24914.0 IU/ml (5147.0-155106.5). The optimal cut-off value for HCMV was determined 778 IU/ml using ROC analysis. Duration of time after transplantation in the viremia and no viremia groups was 120.5 and 46 months, respectively with a statistically significant difference (P=0.014).

Conclusion: This study provides valuable insights into the prevalence of HCMV viremia and its associated risk factors in kidney transplant recipients suspected of rejection. The study also highlights the importance of post-transplant monitoring and preventive measures to address viral infections. Quick and timely diagnosis of viral activation in kidney transplant patients is effective and mandatory for patient management and the use of appropriate preventive and therapeutic strategies that lead to the reduction of nephropathy, transplant rejection and other diseases. Long-term studies with larger sample sizes are needed to evaluate the role of factors influencing the occurrence of viremia after transplantation.

Keywords


1. Higdon LE, Tan JC, Maltzman JS. Infection, rejection, and the connection. Transplantation. 2023;107(3):584-95.
2. Shaeerbaf E, Lotfi Z, Sheikhi M, Shakeri S, Bahrami A. Cytomegalovirus infection among kidney transplant recipients one year after transplantation. J Ilam Univ Med Sci. 2018;26(2):172-9.
3. Alangaden GJ, Thyagarajan R, Gruber SA, Morawski K, Garnick J, El‐Amm JM, et al. Infectious complications after kidney transplantation: Current epidemiology and associated risk factors. Clin Transplant. 2006;20(4):401-9.
4. Ponticelli C. Herpes viruses and tumours in kidney transplant recipients. The role of immunosuppression. Nephrol Dial Transplant. 2011;26(6):1769-75.
5. Vanichanan J, Udomkarnjananun S, Avihingsanon Y, Jutivorakool K. Common viral infections in kidney transplant recipients. Kidney Res Clin Pract. 2018;37(4):323-37.
6. Jabbari M, Sabahi F, Khansari NB, Shirkoohi R, Saberi H, Parvin M, et al. Human cytomegalovirus infection in tumor specimens of Iranian patients with glioma. Prog Biol Sci. 2016;6(1):11-8.
7. Tang Y, Guo J, Li J, Zhou J, Mao X, Qiu T. Risk factors for cytomegalovirus infection and disease after kidney transplantation: A meta-analysis. Transpl Immunol. 2022;74:101677.
8. Al Mana H, Yassine HM, Younes NN, Al-Mohannadi A, Al-Sadeq DW, Alhababi D, et al. The current status of cytomegalovirus (CMV) prevalence in the MENA region: A systematic review. Pathogens. 2019;8(4):213.
9. Herrera S, Bernal-Maurandi J, Cofan F, Ventura P, Marcos MA, Linares L, et al. BK virus and cytomegalovirus coinfections in kidney transplantation and their impact on allograft loss. J Clin Med. 2021;10(17):3779.
10. Afshari A, Yaghobi R, Golshan M. Cytomegalovirus microRNAs level determination in kidney recipients post transplantation. Virol J. 2022;19(1):147.
11. Agrawal A, Ison MG, Danziger-Isakov L. Long-term infectious complications of kidney transplantation. Clin J Am Soc Nephrol. 2022;17(2):286-95.
12. Rangbar KR, Sharifi Z, Mahmoodian SM, Mousavi K. Quantitative analysis of CMV-DNA load in renal transplant recipients using real-time PCR. Iran J Virol. 2011;5(1):31-3.
13. Jabbari MR, Soleimanjahi H, Shatizadeh Malekshahi S, Gholami M, Sadeghi L, Mohraz M. Frequency of cytomegalovirus viral load in Iranian human immunodeficiency virus-1-infected patients with CD4+ counts< 100 cells/mm3. Intervirology. 2021;64(3):135-9.
14. Ashouri Saheli Z, Shenagari M, Harzandi N, Monfared A. Evaluation of prevalence of BKV and JCV DNAs in renal allograft recipients in Guilan province using real-time PCR during 2010-2016. J Ardabil Univ Med Sci. 2019;19(2):149-60.
15. Caliendo AM, St. George K, Kao SY, Allega J, Tan BH, LaFontaine R, et al. Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: Clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients. J Clin Microbiol. 2000;38(6):2122-7.
16. Pullerits K, Garland S, Rengarajan S, Guiver M, Chinnadurai R, Middleton RJ, et al. Kidney transplant-associated viral infection rates and outcomes in a single-centre cohort. Viruses. 2022;14(11):2406.
17. Rahbar M, Amiri M, Poormand G, Poortahmasebi V, Karkhaneh MM, Jazayeri A, et al. Simultaneous detection of opportunistic viral infections among renal transplant patients from Sina hospital, Tehran. Future Virol. 2019;14(6):419-26.
18. Sund F, Lidehäll AK, Claesson K, Foss A, Tötterman TH, Korsgren O, et al. CMV‐specific T‐cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: A pilot study. Clin Transplant. 2010;24(3):401-9.
19. Ghonemy TA, Farag SE, Soliman SA, El-Okely A, El-Hendy Y. Epidemiology and risk factors of chronic kidney disease in the El-Sharkia Governorate, Egypt. Saudi J Kidney Dis Transpl. 2016;27(1):111-7.
20. Pourmand G, Salem S, Mehrsai A, Taherimahmoudi M, Ebrahimi R, Pourmand M. Infectious complications after kidney transplantation: A single‐center experience. Transpl Infect Dis. 2007;9(4):302-9.